サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1690401

酵素結合免疫吸着測定法（ELISA）検査市場レポート：2031年までの動向、予測、競合分析

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

酵素結合免疫吸着測定法（ELISA）検査市場レポート：2031年までの動向、予測、競合分析
出版日: 2025年03月21日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の酵素結合免疫吸着測定法（ELISA）検査市場の将来性は、病院・診断センター、製薬・バイオテクノロジー企業、学術研究センター、臨床検査市場などの機会で有望視されています。酵素結合免疫吸着測定法（ELISA法）の世界市場は、2025～2031年にかけてCAGR 7.5％で成長すると予測されます。この市場の主要促進要因は、HIV、デング熱、肝炎、マラリア、インフルエンザなどの感染症の流行が拡大していることと、複数の感染症を発症するリスクのある高齢者が増加していることです。

  • Lucintelの予測では、タイプ別では、携帯性と現在進行中の技術的進歩により、マルチポータブルELISAが予測期間中に最も高い成長を遂げる見込みです。
  • 最終用途カテゴリーでは、疾病の有病率の増加、個別化医療に対する需要の高まり、ELISA検査に対する政府支援の増加により、病院と診断センターが引き続き最大セグメントとなると考えられます。
  • 地域別では、高齢者の急増、医療機器の普及率の上昇、先進的医療インフラの存在により、北米が予測期間中最大の地域であり続けると考えられます。

酵素結合免疫吸着測定法（ELISA）市場の戦略的成長機会

ELISA検査市場は、さまざまな用途においていくつかの戦略的成長機会を提供しています。

  • 疾病診断：疾病診断：新興疾患や感染症の診断にELISA法の利用が拡大することで、タイムリーかつ特異的な同定が可能になり、大きな成長の可能性が見込まれます。
  • 医薬品開発研究：医薬品開発研究：医薬品開発、特に薬剤動態のモニタリングや治療標的の検証においてELISA検査の利用が増加しており、医薬品における貴重な機会となっています。
  • 環境モニタリング：汚染物質や毒素の環境モニタリングにおけるELISAアプリケーションは、規制の圧力や環境問題への懸念に後押しされて増加しています。
  • 食品安全：食品安全に関する規制の強化や消費者の意識の高まりにより、汚染物質やアレルゲンを検出するための食品検査においてELISAは不可欠なものとなりつつあります。
  • 臨床研究：ELISAはバイオマーカーの探索と検証において重要な役割を果たし、個別化医療と標的治療をサポートすることで、新たな市場機能を開拓しています。

これらのセグメントにおけるELISA用途の拡大が市場の成長を後押ししています。

酵素結合免疫吸着測定法（ELISA）検査の市場の促進要因・課題

ELISA検査市場に影響を与える要因は、技術、経済、規制など多岐にわたります。ここでは、重要な促進要因と課題を分析する

酵素結合免疫吸着測定法（ELISA法）市場を牽引する要因は以下の通りです。

  • 技術の進歩：技術的進歩：新しいELISA技術の発明と開発、自動化、感度の向上などにより、検査の出力と精度が向上し、市場開拓の原動力となっています。
  • 疾患有病率の増加：慢性疾患や感染症の罹患率が増加しています。そのため、ELISA検査を含む効果的で信頼性の高い診断ツールに対する需要が高まっている
  • 政府の取り組み：政府の好意的な施策や研究・医療インフラへの投資がELISA市場を強化しています。
  • 意識の高まり：疾病の早期診断と個別化医療に対する意識の高まりがELISA検査の採用を促進しています。
  • 用途の増加：臨床診断やモニタリングなど、応用範囲の拡大が新たな市場機会を生み出しています。

酵素結合免疫吸着測定法（ELISA）検査市場課題は次のとおりです。

  • コスト高：先進的ELISAシステムと試薬のコストは、資源が乏しい環境での利用を制限する可能性があります。
  • 規制上のハードル：ELISA検査の承認とバリデーションに関する厳しい規制要件は、市場参入を遅らせ、開発コストを増加させる可能性があります。

こうした市場の促進要因・課題がELISA市場を形成し、利害関係者の戦略的意思決定に影響を与えています。

目次

第1章 エグゼクティブサマリー

第2章 世界の酵素免疫測定法（ELISA）検査市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 産業の促進要因と課題

第3章 2019～2031年までの市場動向と予測分析

  • マクロ経済動向（2019～2024年）と予測（2025～2031年）
  • 世界の酵素免疫測定法（ELISA）検査市場の動向（2019～2024年）と予測（2025～2031年）
  • タイプによる世界の酵素免疫測定法（ELISA）検査市場
    • サンドイッチELISA
    • 間接ELISA
    • マルチとポータブルELISA
    • 競合ELISA
  • 用途による世界の酵素免疫測定法（ELISA）検査市場
    • 免疫学
    • ワクチン開発
    • 感染症
    • がん
    • タンパク質の定量
    • その他
  • 最終用途による世界の酵素免疫測定法（ELISA）検査市場
    • 病院と診断センター
    • 製薬・バイオテクノロジー企業
    • 学術研究センター
    • 臨床検査室
    • その他

第4章 2019～2031年までの地域別市場動向と予測分析

  • 地域の酵素免疫測定法（ELISA）検査市場
  • 北米の酵素免疫測定法（ELISA）検査市場
  • 欧州の酵素免疫測定法（ELISA）検査市場
  • アジア太平洋の酵素免疫測定法（ELISA）検査市場
  • その他地域の酵素免疫測定法（ELISA）検査市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • タイプによる世界の酵素免疫測定法（ELISA）検査市場の成長機会
    • 用途による世界の酵素免疫測定法（ELISA）検査市場の成長機会
    • 最終用途による世界の酵素免疫測定法（ELISA）検査市場の成長機会
    • 地域の酵素免疫測定法（ELISA）検査市場の成長機会
  • 世界の酵素免疫測定法（ELISA）検査市場の新たな動向
  • 戦略分析
    • 新製品開発
    • 世界の酵素免疫測定法（ELISA）検査市場の能力拡大
    • 世界の酵素免疫測定法（ELISA）検査市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 主要企業の企業プロファイル

  • Ortho Clinical Diagnostics
  • Thermos Fisher Scientific
  • BioMerieux
  • Sysmex Corporation
  • F. Hoffmann-La Roche
  • Danaher Corporation
  • Quidel Corporation
  • Bio-Rad Laboratories
  • Siemens Healthineers
  • Abbott Laboratories
目次

The future of the global enzyme-linked immunosorbent assay (ELISA) tests market looks promising with opportunities in the hospital and diagnostic center, pharmaceutical and biotech company, academic research center, and clinical laboratory markets. The global enzyme-linked immunosorbent assay (ELISA) tests market is expected to grow with a CAGR of 7.5% from 2025 to 2031. The major drivers for this market are the growing prevalence of infectious diseases, such as HIV, dengue, hepatitis, malaria, influenza, and others, and the growing geriatric population who are at risk of developing several infections.

  • Lucintel forecasts that, within the type category, multiple and portable ELISA is expected to witness the highest growth over the forecast period due to portability and on-going technological advancements.
  • Within the end use category, hospitals and diagnostic centers will remain the largest segment due to the increasing prevalence of diseases, rising demand for personalized medicine, and growing government support for ELISA testing.
  • In terms of regions, North America will remain the largest region over the forecast period due to a surge in geriatric population, rising penetration of medical devices, and presence of well-advanced healthcare infrastructure in this region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

The ELISA tests market is shaped by several key trends:

  • High-Throughput Screening: Automation enables laboratories to adopt high-throughput screening, significantly speeding up sample processing and reducing turnaround times, thus enhancing productivity.
  • Multiplex ELISA: The development of multiplex ELISA tests allows for the simultaneous detection of multiple targets, improving diagnostic accuracy and streamlining workflows by reducing the need for multiple tests.
  • Integration with Digital Platforms: Increasing integration of ELISA systems with digital platforms for data management and analysis enhances result precision and reproducibility through advanced software solutions.
  • Point-of-Care Testing (POCT): There is growing interest in portable and user-friendly ELISA devices for POCT, providing timely diagnostics, especially in remote or underserved areas.
  • Personalized Medicine: ELISA technologies are being adapted for personalized medicine, enabling tailored diagnostic and therapeutic strategies based on individual patient profiles and genetic information.

These trends contribute to the efficiency, accuracy, and accessibility of ELISA tests, driving innovation across various healthcare and research applications.

Recent Developments in the Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

Technological innovations and the rising demand for accurate diagnoses are propelling growth in the ELISA test market. Key developments include:

  • Automation Integration: Automated ELISA systems are transforming laboratory operations by increasing sample throughput and reducing human error, resulting in more consistent and reliable performance.
  • Improved Sensitivity: Advancements in ELISA technology have significantly enhanced assay sensitivity, enabling the detection of low analyte levels and facilitating early disease diagnosis.
  • Portable ELISA Devices: The emergence of portable ELISA devices expands testing capabilities beyond laboratories, allowing for seamless testing in remote or resource-limited settings.
  • Customizable ELISA Kits: The market is seeing more customizable ELISA kits designed for specific research or disease targets, providing greater flexibility and precision in diagnostics.
  • Sustainable Practices: Manufacturers are increasingly focusing on sustainable practices, aiming to reduce waste and use eco-friendly materials in the production of ELISA kits and reagents.

These advancements are enhancing diagnostic capabilities and expanding the scope of ELISA tests.

Strategic Growth Opportunities for Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

The ELISA tests market offers several strategic growth opportunities across various applications:

  • Disease Diagnostics: Expanding the use of ELISA for diagnosing emerging and infectious diseases presents significant growth potential for timely and specific identification.
  • Drug Development Studies: ELISA tests are increasingly utilized in drug development, particularly for monitoring pharmacokinetics and validating therapeutic targets, presenting a valuable opportunity in pharmaceuticals.
  • Environmental Monitoring: ELISA applications in environmental monitoring for pollutants and toxins are growing, driven by regulatory pressures and environmental concerns.
  • Food Safety: ELISA is becoming essential in food testing to detect contaminants and allergens, spurred by increasing food safety regulations and consumer awareness.
  • Clinical Research: ELISA plays a critical role in biomarker discovery and validation, supporting personalized medicine and targeted therapies, thus opening new market capabilities.

The expansion of ELISA applications across these sectors is fueling market growth.

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Driver and Challenges

Factors influencing the ELISA tests market range from technological, and economic, to regulatory. Here is an analysis of some of the important drivers and challenges:

The factors responsible for driving the enzyme-linked immunosorbent assay (ELISA) tests market include:

  • Technological Advancements: Invention and development of new ELISA technologies instance, automation and improved sensitivity-have raised the output and precision of the tests, hence driving market growth.
  • Increased Disease Prevalence: There is now a greater incidence of chronic and infectious diseases. This, in turn, is driving demand for effective and reliable diagnostic tools, which include ELISA tests.
  • Government Initiatives: Favorable government policies and investments in research and health infrastructure enhance the ELISA market.
  • Rising Awareness: Growing awareness of early disease diagnosis and personalized medicine promotes increased adoption of ELISA tests.
  • Increasing Applications: The broadening range of applications, including clinical diagnostics and monitoring, creates new market opportunities.

Challenges in the enzyme-linked immunosorbent assay (ELISA) tests market are:

  • High Costs: The cost of advanced ELISA systems and reagents may limit their accessibility in resource-poor settings.
  • Regulatory Hurdles: Stringent regulatory requirements for the approval and validation of ELISA tests can delay market entry and increase development costs.

These drivers and challenges are shaping the ELISA market and influencing strategic decisions among stakeholders.

List of Enzyme-Linked Immunosorbent Assay (ELISA) Tests Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies enzyme-linked immunosorbent assay (ELISA) tests companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the enzyme-linked immunosorbent assay (ELISA) tests companies profiled in this report include-

  • Ortho Clinical Diagnostics
  • Thermos Fisher Scientific
  • BioMerieux
  • Sysmex Corporation
  • F. Hoffmann-La Roche
  • Danaher Corporation
  • Quidel Corporation
  • Bio-Rad Laboratories
  • Siemens Healthineers
  • Abbott Laboratories

Enzyme-Linked Immunosorbent Assay (ELISA) Tests by Segment

The study includes a forecast for the global enzyme-linked immunosorbent assay (ELISA) tests market by type, application, end use, and region.

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type [Analysis by Value from 2019 to 2031]:

  • Sandwich ELISA
  • Indirect ELISA
  • Multiple and portable ELISA
  • Competitive ELISA

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application [Analysis by Value from 2019 to 2031]:

  • Immunology
  • Vaccine Development
  • Infectious diseases
  • Cancer
  • Protein quantitation
  • Others

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use [Analysis by Value from 2019 to 2031]:

  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotech Companies
  • Academic Research Centers
  • Clinical Laboratories
  • Others

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region [Analysis by Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

The ELISA test market is rapidly evolving with technological advancements and growing diagnostic demands. Recent developments in key markets include:

  • United States: Innovation is thriving, with various high-throughput ELISA systems enhancing efficiency and accuracy to meet diagnostic and research demands.
  • China: There is a focus on developing low-cost ELISA tests to improve accessibility in both urban and rural areas, supported by government initiatives to strengthen public health infrastructure.
  • Germany: Companies are incorporating automation and digitalization into ELISA technology, maximizing laboratory workflow benefits for diagnostics and research.
  • India: The increasing manufacturing of ELISA kits in India is reducing reliance on imports, enhancing the cost-effectiveness and accessibility of diagnostic tools.
  • Japan: Japan is leading in developing multiplex ELISA tests, capable of detecting multiple analytes simultaneously, thus improving disease detection and monitoring efficiency.

Features of the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

Market Size Estimates: Enzyme-linked immunosorbent assay (ELISA) tests market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Enzyme-linked immunosorbent assay (ELISA) tests market size by various segments, such as by type, application, end use, and region in terms of value ($B).

Regional Analysis: Enzyme-linked immunosorbent assay (ELISA) tests market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the enzyme-linked immunosorbent assay (ELISA) tests market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the enzyme-linked immunosorbent assay (ELISA) tests market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M&A, and more.

This report answers the following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the enzyme-linked immunosorbent assay (ELISA) tests market by type (sandwich ELISA, indirect ELISA, multiple and portable ELISA, and competitive ELISA), application (immunology, vaccine development, infectious diseases, cancer, protein quantitation, and others), end use (hospitals and diagnostic centers, pharmaceutical and biotech companies, academic research centers, clinical laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

  • 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
  • 3.2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Trends (2019-2024) and Forecast (2025-2031)
  • 3.3: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type
    • 3.3.1: Sandwich ELISA
    • 3.3.2: Indirect ELISA
    • 3.3.3: Multiple and portable ELISA
    • 3.3.4: Competitive ELISA
  • 3.4: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application
    • 3.4.1: Immunology
    • 3.4.2: Vaccine Development
    • 3.4.3: Infectious diseases
    • 3.4.4: Cancer
    • 3.4.5: Protein quantitation
    • 3.4.6: Others
  • 3.5: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use
    • 3.5.1: Hospitals and Diagnostic Centers
    • 3.5.2: Pharmaceutical and Biotech Companies
    • 3.5.3: Academic Research Centers
    • 3.5.4: Clinical Laboratories
    • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

  • 4.1: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region
  • 4.2: North American Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 4.2.1: North American Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
    • 4.2.2: North American Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
  • 4.3: European Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 4.3.1: European Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
    • 4.3.2: European Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
  • 4.4: APAC Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 4.4.1: APAC Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
    • 4.4.2: APAC Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
  • 4.5: ROW Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 4.5.1: ROW Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
    • 4.5.2: ROW Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type
    • 6.1.2: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application
    • 6.1.3: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use
    • 6.1.4: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region
  • 6.2: Emerging Trends in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Ortho Clinical Diagnostics
  • 7.2: Thermos Fisher Scientific
  • 7.3: BioMerieux
  • 7.4: Sysmex Corporation
  • 7.5: F. Hoffmann-La Roche
  • 7.6: Danaher Corporation
  • 7.7: Quidel Corporation
  • 7.8: Bio-Rad Laboratories
  • 7.9: Siemens Healthineers
  • 7.10: Abbott Laboratories